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Abstract 
 
 
  Mechanical conditioning is an important factor when designing tissue engineered blood 
vessels.  In order for the tissue to undergo mechanical conditioning, the tissue itself must be 
able to withstand the strains and pressures applied to it.  Collagen is naturally produced by cells 
and imparts strength to multicellular tissue, but treating the vascular tissue with ascorbic acid 
can further increase collagen production, thus making the tissue stronger.  This work aims to 
examine ascorbic acid treatment to optimize collagen production in cell-derived engineered 
tissue rings, as well as to design a device to mechanically condition these ring constructs. This 
device will be used to dynamically culture tissue rings and optimize engineered tissue growth 
and maturation in culture.  
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1.0 Introduction: 
 
Coronary artery bypass surgery has become a widespread surgery in the United States, 
and since 2007 there have been more than 427,000 surgical procedures involving small-caliber 
blood vessels (American Heart Association, 2008).  Coronary artery bypass surgery is necessary 
when a patient’s artery becomes blocked and blood needs to be rerouted around the blockage 
to keep the blood flowing and tissue oxygenation (Schaffer, 2007).  Currently, most of these 
surgeries are completed by taking autologous blood vessels from elsewhere in a patient’s body, 
such as the internal mammary artery and saphenous vein, and using them to reroute blood 
around the blocked artery (Isenberg et al, 2006).   
Due to complications and limitations of using autologous blood vessels for 
transplantation in coronary artery bypass surgery, tissue engineering is being explored as an 
alternative source of vascular grafts. The benefit of a tissue engineered method becomes 
apparent when recognizing the need for blood vessels that are small in diameter (≤6mm), 
similar to the ones they are replacing. Patients lacking in suitable small-caliber vessels for 
replacement in the coronary artery due to vascular disease, amputation, or previous harvest 
(Isenberg et al., 2006) would especially benefit from a tissue engineering approach to address 
the need for alternatives.  
Many different techniques have been experimented with to produce a suitable vessel 
through tissue engineering techniques that can be used in coronary bypass surgeries.  Although 
the ultimate goal is to generate a functional tissue replacement made entirely of living cells and 
their extracellular matrices, the process in which these vessels are constructed can vary.  Five 
approaches that address the complicated architecture and unique mechanical properties of the 
vascular wall are endothelial cell (EC)-seeded synthetic grafts, cells suspended in fibrin or 
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collagen-gels, biodegradable synthetic polymer-based constructs (with or without seeding), cell 
sheet-based blood vessels, and decellularized tissue approaches to vascular graft engineering 
(Seliktar,2000). Though these novel procedures have made significant strides in creating fully 
functional engineered vasculature, significant limitations still prevent their clinical use. These 
include limitations in having the cells adhere to the synthetic polymers and ensuring the 
mechanical integrity of the constructs in vivo. Furthermore, the goal of developing a fully 
functional vascular graft will likely require knowledge gained from each one of these 
approaches.  
The aim of this project is to assess the addition of varying concentrations of ascorbic 
acid to human dermal fibroblasts cultured as cell-derived tissue rings, to increase collagen 
production.  An additional goal of this project was to create strong, collagen-rich tissue rings to 
mount and test in the Vessel Ring Bioreacter (KLB 0904, 2009), designed to mechanically 
condition the vascular rings as models for full-length, tubular blood vessels. Although it is 
beyond the scope of this project, of extreme relevance to the field of research would be to 
mechanically test and compare the viscoelastic properties of mechanically conditioned rings 
with those grown in a static culture.  
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2.0   Background 
 
Coronary heart disease is the leading cause of death in men and women in the United 
States (Michaels, 2002). Consequently, coronary artery bypass graft (CABG) surgery is one of the 
most common operations performed throughout the world (Eagle, 2004).  CABG surgeries are 
mainly conducted because plaque forms in the coronary arteries resulting in a process known as 
atherosclerosis, or hardening of the arterial walls (Parmet, 2008).  This plaque blocks the 
arteries, decreasing blood flow and oxygen to the heart, causing angina and myocardial 
infarction (American Heart Association, 2008).  CABG operations take blood vessels, usually from 
elsewhere in the patient’s body, and use those vessels to bypass the blockage (Isenberg, 2006).  
Preferably, small caliber blood vessels like the saphenous vein, radial arteries and internal 
thoracic arteries should be used since they are close in size and function to the blocked vessel. 
Figure 1 shows a cartoon of a CABG procedure.  
 
Figure 1 - Coronary Artery Bypass Graft (© 1997- 2008 A.D.A.M., Inc.) 
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  Functional problems arise when small caliber (<6mm) are unavailable (Isenberg et. al., 
2006).  Although synthetic grafts have been explored as an alternative, the low blood flow 
environment in these arteries is associated with increased thrombogenicity and intimal 
hyperplasia, leading to synthetic graft failure (Shastri, 2004). Tissue engineering has emerged as 
a promising alternative that may limit the effects of thrombogenisis due to their biological 
origin. An ideal bioengineered graft would be mechanically strong and pliable, non-
immunogenic, non-thrombogenic, easy to handle, and cheap to produce (Shastri, 2004). 
One of the major differences between synthetic, tissue-engineered and autologous 
conduits is the presence in the latter of a living functional layer of endothelial cells resting on a 
metabolically active, smooth muscle cell media. Current synthetic grafts, lack these properties 
and are unable to ‘heal’ completely in humans, failing to achieve the necessary tissue ingrowth 
that would encourage coverage of the lumenal surface by endothelial cells (Tiara et. al., 2001). 
These blood vessels, whether prosthetic or tissue-engineered must be able to withstand the 
pressures of the human body and they must possess the appropriate mechanical and biological 
properties needed to make them indistinguishable from the native cells and vessels (Isenberg et. 
al, 2006). It is widely held that 3 components are necessary for these criteria to be met: (1) a 
biocompatible component with high tensile strength to provide mechanical support (collagen 
fibers or their analogue); (2) a biocompatible elastic component to provide recoil and prevent 
aneurysm formation (elastin fibers and their analogue); and (3) a non-activated, confluent 
endothelium to prevent thrombosis (Isenberg and Tranquillo, 2003). The different techniques 
for engineering vasculature address these criteria, each with their own advantages and 
disadvantages.  
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2.1 Definition of Mechanical Conditioning 
An efficient arterial replacement graft needs to not only function biologically like a 
natural vessel but also must function mechanically like a natural vessel. Mechanically, a vessel 
needs to be able to withstand shear stress, pressure and stretching due to blood pressure, and 
longitudinal tension along the vessel (Isenberg et al, 2006).  There have been different methods 
established to replicate natural vessel properties, such as varying cell culture conditions and cell 
types, but a promising, recently developed method is mechanical conditioning, or dynamic 
stimulation (Isenberg et al, 2006, Sung In Jeong et al., 2005, Cummings et al., 2004, Isenberg and 
Tranquillo, 2003). Several studies have shown that in vitro-cultured arterial cells that are 
exposed to mechanical signals, (like those experienced by natural vessels) develop many 
attributes of efficient vascular grafts for in vivo usage. Such attributes include enhanced 
mechanical strength, collagen production, cell alignment, and regulated phenotype of vascular 
smooth muscle cells (Isenberg et al, 2006, Sung In Jeong et al., 2005, Cummings et al., 2004, 
Isenberg and Tranquillo, 2003). It has been shown that mechanical stretching promotes the 
expression of type I and III collagens, fibronectin, and tenascin-C in cultured ligament fibroblasts 
(Sahoo et. al., 2007). Another study indicated that human bone marrow mesenchymal stem cells 
(hBMMSC) - even in the absence of biochemical regulators - could be induced to differentiate 
into ligament-like fibroblast by the application of physiologically relevant cyclic strains (Vunjak-
Novakovic et. al., 2004).  Therefore, mechanical conditioning has become a primary strategy for 
inducing tissue growth and maturation in vitro (Freed et. al., 2000).  An assortment of 
bioreactors have been manufactured to expose cell structures to mechanical stimulation 
(Isenberg et al, 2006). However, these bioreactors have never been used to test the effects of 
different culture conditions, a goal that the team hopes the design accomplishes. These 
experimental parameters can be growth factors, such as cell and media type, that contribute to 
changes in the architecture of the extacellular matrix.  As seen in Figure 2, the team plans to use 
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this bioreactor to combine both methods of cyclic distention and growth factors to obtain 
experimental results. The problem is illustrated in the schematic below. 
 
Figure 2 - Optimizing Effects of Dynamic Conditioning and Growth Factors 
 
 
2.2 Tissue Engineered Blood Vessels 
  There are many different ways that blood vessels can be constructed using tissue-
engineered techniques.  The ultimate goal is to create a blood vessel made entirely of cells and 
their extracellular matrices.  Many of these methods use scaffolds for the cells to aggregate 
around (Isenberg et al., 2006).  One method starts with biodegradable scaffolds on which cells 
are seeded and allowed to produce their extracellular matrix (Isenberg et. al., 2006). Once 
visible tubes are formed the cells are washed away and only the matrices are left, leaving the 
tubes acellular (Schaffer, 2007).  In theory these acellular tubes are then to be implanted into 
the patient and repopulated by the body’s own cells (Schaffer, 2007). Biodegradable polymer 
scaffolds and biopolymer gels are also methods used to generate tubular vessels (Syedain et. al., 
2008).  The cells are seeded onto a multitude of different biodegradable synthetic polymer 
scaffolds or gels and once the cells have formed into vascular tubes the polymer dissolves 
leaving behind a hollow vascular tube (Isenberg et. al., 2006, Syedain et. al., 2008).   
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 Another method to produce blood vessels is growing the cells into two dimensional 
sheets and then rolling them into the shape of a tube (L’Heureux et. al., 2007).  The sheets are 
made completely from cells and no synthetic or exogenous materials are used (L’Heureux et. al., 
2007).  The tubes are created from multiple layers of cells that fuse together to create a tube 
that will withstand the pressures of the human body (Isenberg et. al., 2006).  The cell sheets are 
grown on culture plate and then wrapped around a porous tubular mandrel and an outer layer 
of cells is wrapped around that to construct the adventitia, which is the outermost connective 
tissue of the vessel (L’Heureux et. al., 2007).   
 While all of the above methods ultimately end in the production of a tissue-engineered 
blood vessel they all have major problems that need to be addressed.  All of the methods 
involving scaffolds as well as those vessels made from sheets have a lack of compliance that 
keeps the vessels from performing to their full potential (Isenberg et. al., 2006).  The vessels 
made from decellularized tissues have experienced reduced tensile strength and a lack of 
compliance (Isenberg et. al., 2006).  A lack of compliance implies high stiffness. The vessels 
made on biodegradable scaffolds have experienced premature weakening of the tissue 
(Isenberg et. al., 2006). The lack of compliance prevents the engineered vessels from 
maintaining their structural integrity, as such vessels undergo unrecoverable plastic 
deformation. Better methods for constructing tissue-engineered blood vessels have greatly 
improved the mechanical properties of these constructs.  
 Rather than generate an entire blood vessel and then take sections of it to mechanically 
test, some researchers are growing cellular rings that have the same properties as an entire 
blood vessel and are testing them as model representation of small diameter vasculature 
(Isenberg and Tranquillo, 2003).  This representation is shown in the schematic below. 
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Figure 3 - Rings as Tube Models 
 
This technique is both easy to replicate and time efficient. Since investigators have not 
yet been able to develop a fully functional bioartifical artery (BAA) that meets the requirements 
for mechanical strength and biological functionality (Isenberg and Tranquillo, 2003), the idea of 
creating rings that mimic BAAs is an approach that will allow researchers to have a biological 
model through which to study and improve the functionality of tissue-engineered vasculature.  
  
2.3 Cell Derived Matrix 
       Patients that have undergone myocardial injury have scar tissue from local remodeling that 
inhibits the vessels from functioning properly and they must have vascular grafts implanted to 
continue smooth functioning of the heart and vessels (Bunda et al, 2007).  In previous studies 
vascular rings, which are models for tissue engineered blood vessels, have been made from cells 
other than cardiac myocytes, so therefore the cellular matrix must be adjusted to withstand the 
pressures of the heart and blood vessels (Bunda et al, 2007).   
 The cells that these vessels are made of become an important decision because they 
have to be compliant with the rest of the system as well as be able to function like cells in blood 
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vessel. Smooth muscle cells and dermal fibroblasts are two types of cells that are very common 
among previous studies (Bunda et al, 2007).   
 The cell matrix is also a very important part of the vascular tissue.  Different types of 
cells lay down different matrix components and it is crucial to have the correct ratio of cellular 
matrix components to create an ideal vascular tissue to be used in such grafts.   
2.3.1 Collagen Production 
 Collagen fibers are made of tropocollagen which are triple helix and are composed of 
three extended protein chains that wrap around one another (Alberts et al, 2004).  Collagen 
molecules are cross-linked in the ECM to form collagen fibrils which form collagen fibers which 
can be seen in Figure 4 (Berwal and Novakofski 1999).  Collagen is a glycoprotein composed of 
galactose and glucose which have intermolecular cross-linkages and because of these, have high 
tensile strength (Berwal and Novakofski 1999).  Collagen is more rigid than elastin and rarely 
branches like elastin usually does (Berwal and Novakofski 1999).  Collagen is needed in the ECM 
because it keeps the tissue strong and rigid.  Collagen is as strong as steel which will help the 
cells to withstand the pressures of the heart and vessels.     
 Hydroxyproline is a modified amino acid exclusive to collagen and ascorbate has been 
shown to contribute to the metabolic processes which produce hydroxyproline, leading to 
collagen production (Davidson et al, 1997).  The amount of ascorbate added to the cells in 
culture has a direct affect on collagen production; the more ascorbate that is added, the more 
collagen is produced (Davidson et al, 1997).   
  
 Ascorbate is a cofactor in the enzyme activity of hydroxylase which stimulates collagen 
production and is needed for collagen to attain its triple helix formation under physiological 
 16 | P a g e  
 
temperatures (Davidson et al, 2007). Based off of the data collected by Davidson et al, ascorbate 
added to human dermal-fibroblasts at varying concentrations (0, 0.5, 5, and 25 µg/mL) produced 
different amounts of collagen in the cell’s ECM.   
 
Figure 4 - Collagen Fiber (Alberts et al, 2004) 
 
 
 
 
2.4 Hypothesis: 
 The working hypothesis for this project is that ascorbic acid treatment will increase 
collagen production and would thereby increase the tensile strength of the tissue.  To test this 
hypothesis vascular rings were cultured and treated with varying concentrations of ascorbic acid 
and were analyzed for collagen production using histochemical methods.   
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3.0 Methods and Materials 
3.1 Cell Culture  
 Human dermal fibroblasts were grown in DMEM (Mediatech, Herndon, VA)  
supplemented with: 10% fetal bovine serum (FBS), 1% non-essential amino acids, 1% pen/strep, 
1% pyruvate, and 1% glutamine.  This media will later be referred to as growth medium.   The 
cells were grown in T75 flasks until they were 90% confluent in the incubator at 37°C and 5% 
CO2.  If the cells were from a frozen stock they were thawed and plated with 10mL of the growth 
medium.  If the cells were passaged, the supernatant was aspirated out from the T75 flask, and 
the cells were washed with 5mL of phosphate buffer saline (PBS).  The cells were then 
trypsinized with 5mL of trypsin (Media Tech), and were left to sit until the cells detached from 
the bottom of the flask.  The cells were then mixed with 5mL of the growth medium to 
deactivate the tryspin and were transferred to a 15mL conical tube.  The tube was then 
centrifuged for 5 minutes at 1,000 rpm.  If the cells were being counted 100µL was added to 
100µL of trypan blue, and 10 µL of the solution was added to each side of the hemocytometer 
and counted using a microscope with 100x magnification (10x objective).  Figure 5 shows one of 
the grids of a hemocytometer.  The four corners were counted on each side of the 
hemocytometer to calculate the total amount of cells.  If the cell fell on the line, the cell was 
counted “in” if the line was on the top or right side of the square.  If the cell fell on the bottom 
or left side of the square the cell was not counted.  Once the number of cells in the four corners 
on both sides of the hemocytometer were counted, this number was divided by eight to get the 
number of cells per square and then multiplied by 10,000 to convert to the number of cells per 
mL.  This number was then multiplied by 10 to get the total number of cells per T75 flask.    
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Figure 5 - Hemocytometer Chamber (Caprette, David, 2000) 
  
 
3.2 Preparation of Cellular Rings 
 Once the human dermal fibroblasts were ready to be cultured into the rings the 
following protocols were used.  The protocols found below follow the schematic found in Figure 
6.   
 
Figure 6 - Schematic of Ring Protocols 
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3.2.1 Making a PDMS Template  
 
Figure 7 - Polycarbonate Mold 
  A polycarbonate mold was machine containing 15 annular wells with inner posts of 2 
mm (Figure 7).  The wells were machined with round bottoms so that the cells could aggregate 
around the posts to form rings.   The polycarbonate mold was washed with warm soapy water 
to rid it of dirt and bacteria and tapped dry before each use. The polycarbonate mold was then 
placed in a plastic container and set aside.   A mixture of 10:1 silicone elastomer base and 
silicone elastomer cure agent were used to create the PDMS (Polydimethylsiloxane, Sylgard 184 
silicone elastomer kit, Dow Corning, Midland, MI) template; 110g of base and 11g of curer were 
mixed well and placed in a vacuum chamber to remove the bubbles for 20 minutes.  The plastic 
container with the polycarbonate template was the filled with the PDMS and allowed to sit in 
the vacuum for 40 minutes to remove any additional bubbles.  This container was then placed in 
the oven at 60°C overnight.   The PDMS template and polycarbonate mold were cut out of the 
plastic container using a scalpel and the PDMS template was peeled off of the polycarbonate 
mold (Figure 8).  Before the PDMS template could be used for any experiments it was placed in 
an autoclavable bag and autoclaved first.  The PDMS template must be autoclaved before each 
experiment.    
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Figure 8 - PDMS Template 
3.2.2 Media Concentrations of Ascorbic Acid 
Cells were treated with varying concentrations of ascorbic acid:  0, 10µg/mL, and 100 
µg/mL ascorbic acid.  To create these concentrations 0.1 g of Ascorbic Acid (Sigma) was 
dissolved in 10mL of serum free DMEM.  This solution was then sterilized by passing through a 
0.2µm sterile filter and into a 15mL conical tube.  This tube was labeled 100µg/mL and became 
the ascorbic acid stock solution (high concentration stock; 0.01 g/mL).  Then 1mL of the 
100µg/mL ascorbic acid solution was placed in a new 15mL conical tube and added to this was 
9mL of serum free media.  This solution was 0.001g/mL ascorbic acid and became the low 
concentration of ascorbic acid stock solution.  The control for the experiment was 0µg/mL 
ascorbic acid.  This was created by placing 10mL of serum free media in a separate tube and 
labeled 0µg/mL. 
 Once the stock solutions were made 0.5 mL of each stock solution was added to 49.5mL 
of growth medium.  This media was then used for the following procedures.   The working 
concentrations of ascorbic acid applied to the fibroblasts were 0µg/mL, 10µg/mL, and  
100µg/mL.  Figure 9 shows a schematic of the serial dilutions used to create the stock solutions 
and working media.   
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Figure 9 - Preparation of Ascorbic Acid Stock Solution 
3.2.3 Making Agarose  
 Each PDMS template required 100mL of 2% agarose to fill the template.  The 2% 
agarose mixture was made using 2g of agarose mixed with 100mL of serum free DMEM.  This 
mixture was then autoclaved at 121°C.  For each replication of the entire experiment 3 PDMS 
molds were used so a total of 6g of agarose and 300mL of serum free DMEM were autoclaved at 
the same time. 
3.2.4 Making Agarose Wells      
 Once the agarose was autoclaved and still hot, it was transferred into the PDMS 
templates in the cell culture hood.  Each inner ring of the molds was filled carefully using an 
automatic pipetter set at 100µL.  Once each of the inner rings was full and no air bubbles were 
seen, the rest of the mold was filled using a 25mL pipette.  This same process occurred for all 
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three PDMS templates.  These molds were then left to solidify in the cell culture hood for 1 
hour.       
 Once the agarose molds had solidified, each well was individually cut out of the mold, 
and placed into a 6 well plate.  Before this part of the experiment began, two spatulas and a 
scalpel must have been autoclaved in an autoclavable bag.  Six, 6 well sterile plates must have 
also been obtained before beginning.  Each well was then carefully cut out of the mold using the 
scalpel and placed into a well of the 6 well plates.  For each experiment, 32 rings were made so 
a total of six, 6 well plates were used.  Once all the wells were cut and placed into the 
appropriate dishes, media was added to allow them to equilibrate.  Each well was filled with 
6mL of media, and each media type (0µg/mL, 10µg/mL, and 100µg/mL) was used to fill three 
plates.  Overall there were twelve wells for each type of media.  These wells were left to 
equilibrate in media, in the incubator for 90 minutes prior to cell seeding. 
3.2.5 Seeding Rings 
 Once the wells were equilibrated they were seeded with cells.  Each ring started with 1 
million cells and each six well plated required approximately one T75 flask of HDF.  The cells 
were trypsinized from  the flask using the protocol found in (3.1 Cell Culture) but before the cells 
were placed in a 15mL conical tube they were counted using the protocol found in 3.1 Cell 
Culture.  Once the total number of cells was known, a customized program, developed by Jason 
Hu in the Rolle Lab, gave the exact amount of media that needed to be centrifuged to make six 
rings.  This amount of cell suspension was centrifuged at 1,000 rpm for 5 minutes.  The 
supernatant was then removed, and added to it was 816µL of the corresponding media.  If the 6 
well plates were equilibrated with 0µg/mL media, then 0µg/mL media was added to the cells to 
create rings.  136µL of media was used to seed each ring.  The rings were seeded around in the 
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inner well of the mold in a circular motion.  Once the rings were seeded they were left 
undisturbed for 48 hours in the incubator and were fed every two days after that and harvested 
at 7 and 14 days.  Figure 10 shows one ring around the agarose post in the well.  Each time the 
cells were fed they were fed with the appropriate media.   
 
Figure 10 - HDF Ring in Well after 7 Days 
3.3 Experimental Design 
 The following experimental design was used for the seeding the rings:  
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Figure 11 - Ascorbic Acid Experimental Design 
For each experiment, two 6 well plated were seeded per ascorbic acid concentration.  
Each time frame had one 6 well plate and the entire experiment was repeated three times.  
Three rings from each plate (n=3) were harvested for histochemical staining and the other three 
were frozen for Sircol (Sigma) and CyQuant (Invitrogen) assays.   
 
 
0 µg/mL Ascorbic Acid  10 µg/mL Ascorbic Acid  
100 µg/mL Ascorbic Acid 
Day 7- n=6 
 
Day 14- n=6 
Day 7- n=6 
 
Day 14- n=6 
Day 7- n=6 
 
Day 14-n=6 
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3.4 Harvesting Vascular Rings 
3.4.1 Harvesting 7 and 14 Day Rings 
 When the rings had been cultured for 7 or 14 days, each set of rings was harvested.  
Using a pair of bent needle nose forceps, the rings were slid off of their posts one by one and 
placed in PBS which can be seen in Figure 12.  They were then dabbed dry on Lens Paper and 
placed in a 2 in X 2 in lens paper square to retain the ring within the cassette during processing.  
The lens paper was then folded and placed in a cassette which was placed in neutral buffer 
formalin.  This was done for each concentration at each time stamp.  The samples were then 
processed and embedded in paraffin.  The cassettes were then cut in 5µm sections and placed 
onto glass slides.   
 
Figure 12 - HDF ring washing in PBS 
3.4.2 Histochemical Staining 
 For each ring, one of the slides prepared was used for a Masson trichrome stain and 
another was used for a Movat’s pentachrome staining.  The protocols for these procedures can 
be found in Appendix A.   
 The Masson trichrome stains three different colors with each color corresponding 
different cellular and matrix components. Cytoplasm and keratin stained red.  Nuclei stained 
black, and collagen stained blue.   
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 The modified Movat’s pentachrome stains five different colors with each color 
corresponding to a different part of the tissue. Nuclei and elastic fibers stained black, 
glycosaminoglycans stained blue, cells and cytoplasm stained red, and collagen stained yellow.  
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4.0 Results 
 The entire experiment was repeated three times for each concentration and each time 
point for a total of 36 rings for each experiment.  Due to contamination and non-salvageable 
rings, not all of the rings for each concentration were harvested and analyzed.  Table 1 shows 
the total amount of rings harvested and analyzed for trichrome and pentachrome staining.  
There were also 8 rings frozen for sircol and cyquant assays which were not completed due to 
time restraints.   
Table 1 - Total Number of HDF Rings Analyzed 
 Day 7   Day 14   
Experiment 0µg/mL 10µg/mL 100µg/mL 0µg/mL 10µg/mL 100µg/mL 
1* 0 0 0 0 0 0 
2 1 3 3 2 0 0 
3 2 0 1 0 0 2 
Total: 3 3 4 2 0 2 
*Experiment 1 produced zero rings to improper seeding methods. 
 Vascular rings were also cultured for a mechanical conditioning device that is discussed 
in Chapter 6.  These rings were cultured in growth medium without the addition of ascorbic 
acid.   For this experiment six rings were cultured at a time and the entire experiment was 
repeated four times.  At this time none of the rings have successfully been mechanically 
conditioned due to contamination or breakage of the ring.    
4.1   7 Day Treatments 
 Each salvageable ring from the 7day Ascorbic Acid treatments was harvested and 
stained using the trichrome and pentachrome staining.   A representative sample from all of the 
experiments can be seen in Figure 13. 
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Treatment Trichrome 20x Trichrome 40x Pentachrome 20x Pentachrome 40x 
0µg/mL 
 
   
10µg/mL 
 
  
 
100µg/mL 
 
 
 
 
Figure 13 - 7 Day Treatments 
 
4.2 14 Day Treatments 
 Due to contamination and non-salvageable rings there were not enough rings from the 
14 day treatments to have accurate results.  The images below were parts of rings or clumps of 
cells that were grown at the given concentrations and stained.    
4.2.1 0µg/mL Ascorbic Acid Treatments at 14 Days 
 Figure 14 shows the rings harvested at 14 day with 0µg/mL Ascorbic Acid.   
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Trial 
# 
Ring 
# 
Trichrome 20x Trichrome 40x Pentachrome 20x Pentachrome 40x 
1 2 
 
   
1 3** 
 
 
  
Figure 14 - 14 day 0µg/mL Ascorbic Acid Trichrome and Pentachrome Stains 
**Trial 1, Ring 3 was not actually a ring.  The cells were in a ball and the ‘clump’ of cells was 
tested.   
 
 
4.2.2 10µg/mL Ascorbic Acid Treatments at 14 Days 
 There were no salvageable rings for the 14 day 10x Ascorbic Acid treatments for either 
trials due to contamination and/or poor harvesting methods.   
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4.2.3 100µg/mL  Ascorbic Acid Treatments at 14 Days 
 Figure 15 shows the rings harvested at 14 day with 100µg/mL Ascorbic Acid.   
 
Trial 
# 
Ring 
# 
Trichrome 20x Trichrome 40x Pentachrome 20x Pentachrome 40x 
 
2 
 
1 
 
 
  
 
2 
 
2 
  
  
 
Figure 15 - 14 day 100µg/mL Ascorbic Acid Trichrome and Pentachrome Stains 
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5.0 Discussion  
 Over the past five months three full experiments were completed and a total of 22 rings 
were harvested.  A total of 14 rings were analyzed using trichrome and pentachrome stains 
while 8 rings were frozen for sircol and cyquant assays which were not completed due to time 
constraints.  With increasing amounts of ascorbic acid, it was shown that there was a visible 
change in the ECM of this human dermal fibroblast tissue.  This can be seen in Figure 10 by the 
increase in ‘red’ color and the decrease in ‘blue’ seen in the pentachrome stain.   This 
observation suggests  that there was a decrease in gylocosaminoglycans and an increase in cells 
and cytoplasm within the tissue.  Although collagen was not easily seen in the tissue, a decrease 
in gylocosaminoglycans and an increase in cells and cytoplasm could potentially make the tissue 
stronger which would accomplish the overall goal of the project; to increase the initial strength 
of the tissue.  There were no noticeable changes in the 7day treatments when it came to the 
trichrome stains which could be because the black and dark blue stains are so similar that it was 
hard to distinguish the two.     
 There were no useful results from the 14day treatments due to contamination in the lab 
and rings that were not salvageable.  Some of the rings were ruined as they were being taken off 
of the agarose posts.  These rings fell apart and could not be analyzed for collagen content.   
 In an ideal situation, each experiment would have produced 32 viable rings, but overall 
contamination was an ongoing problem for both 7 and 14 day treatments leaving only a total of 
14 rings that could be analyzed for collagen.   
 Davidson published a paper in 1996 using varying concentrations of ascorbic acid 
cultured with pig skin fibroblasts (Davidson et al, 1996).  They stained the tissue sections with 
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hematoxylin and eosin, which was not done during this project, but they did see an increase in 
collagen production with an increase in concentration of ascorbic acid.   
 Overall there was not a noticeable increase in collagen production within the human 
dermal fibroblast rings, but there was a significant change in the ECM of the 7day treatments.  
This shows that the ascorbic acid could be increasing the strength of the tissue just not in the 
manner that was first expected.   
5.1 Future Work 
 This project leaves many opportunities for future work.  The rings originally frozen for 
sircol and cyquant assays are still in the freezer so that these tests can be done at a later date.  
Both of these assays analyze for DNA content which will be able to be correlated with cell count.  
Once the cell count is known for the final rings, it can be compared to the original 1 million cells 
that were seeded.   
 The rings can also be treated with different growth factors to increase different proteins 
within the cellular tissue that might help to increase strength and flexibility so that the rings can 
better withstand mechanical testing.   
 Once the optimal culture conditions have been developed, the rings can be 
mechanically conditioned to further increase tissue strength. Both of these methods seem very 
promising for increasing tissue strength and reaching the ultimate goal of creating a tissue that 
can be used to make vessels for coronary artery bypass surgeries.  The future work with these 
rings has many different directions it can take and all of them seem very promising.   
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6.0 Mechanical Conditioning Device (Ali et al, 2009) 
 This chapter is a small part in a much larger Major Qualifying Project that was 
completed with three mechanical engineer students and me.  Chapter six of this paper shows 
the biological aspect of the vessel ring bioreactor as well as the finished design. 
6.1 The final mechanical conditioning device 
 This device was designed to mechanically condition vascular tissue.  This device will be 
used to dynamically condition rings of vascular tissue created by cells in culture without the use 
of a scaffold.  This device creates a high-throughput and accurate yet inexpensive, dual-
regulated pressure source as well as an electronic valve controller to cyclically inflate up to 32 
ring segments cultured on a series of silicone tubes encased in standard 50mL sterile conical 
tubes.  This device will be used to determine the dynamic culture conditions that optimize 
engineered vessel growth and maturation in culture (Figure 16). 
 
 
Figure 16 - Final Design 
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6.2 Individual Media Chambers 
 Tissue engineered vascular rings will be placed on flexible, inflatable tubing, with 
up to four rings on each tube, as shown in Figure 17. To ensure cell compatibility, and the 
appropriate mechanical strength for dynamic loading, silicone was recognized and 
verified as a suitable option. The outside diameter of the silicone tubing will be slightly 
smaller than the vascular rings. The flexible silicone tubing is connected to a threaded 
barb, by a heat-sensitive sleeve. The threaded barb screws onto the cap of a media 
chamber. A hole was drilled on to the cap to ensure that the threaded barb fits through the 
cap. An air pressure fitting screws on to the top of the barb on the opposite side of the 
cap. On the underside of the media chamber cap, between the cap and the barb 
connector’s hex head, an o-ring ensures that there is no leaking between the hole made in 
the cap and the outside environment. The barb and the silicone tube are housed inside the 
media chamber, with the appropriate media. A sterile air filter was attached to the cap to 
allow the media to obtain oxygen.  Eight such units are attached to the manifold (Figure 
16).  The numerous separate chambers allow for the high throughput required of the 
design.  The 50mL conical tube bases can be changed easily when fresh media is required 
for feedings since they are readily available in large quantities.  
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Figure 17 - Individual Media Chamber 
 
6.2.1 Ring Method for Media Chambers 
 The same method for seeding rings for the media chambers was described in chapter 
3.2.  The only difference between these two methods is that the rings cultured for the 
mechanical conditioning device were cultured in growth medium instead of media with ascorbic 
acid.   
6.3 Loading the Vascular Rings 
 In order for the device to mechanically condition the vascular rings in culture 
one must be able to successfully load the rings onto the silicone tubes without damaging them.  
To test the silicone tubing idea rings were cultured and loading of these rings was attempted.  
The attempted loading occurred on the bench top so the rings were not viable after testing.  
When this machine is used the ring loading process must occur within the cell culture hood to 
maintain sterility.  After many attempts, the design seen in Figure 18 was established.  A 
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hypodermic needle was glued into the bottom on the silicone tubing which allows the user to 
pierce the center of the agarose well to help hold the tube in place.  Once the silicone tube is in 
the center of the agarose well the user can take bent needle nose forceps and ‘roll’ the ring up 
the tube to its desired location (Figure 19).  The tube with the ring on it will then be placed in a 
50mL conical tube with the desired media.     
 
Figure 18 - Silicone end tubing design 
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Figure 19 - Loading the Rings 
 
 During this project the rings were not successfully loaded onto the silicone tubing 
because the tubing used was 2mm and the post the rings were grown in was 2mm.  In order for 
the rings to successfully be loaded onto the tubing these two must line up perfectly without any 
room for the rings to roll up inside of the silicone tubing.  To fix this problem the rings will be 
grown around 2.25mm posts during future work.   
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8.0 Appendix 
 
Masson Trichrome Protocol 
The following reagents were used for the trichrome staining: 
Bouin’s Solution (Sigma HT10-1-128) 
Weigert Iron Hematoxylin: 
 -Solution A  (Sigma HT107-500mL 
 -Solution B (Sigma HT109-500mL) 
 -Working Solution: Mix equal parts of solutions A and B 
Biebrich Scarlet-Acid Fuchsin Solution (HT151-250mL) 
Phosphomolybdic/Phosphotungstic Acid Solution 
 -Working Solution 
  -1 part: Phosphomolybdic Acid Solution (HT153-250mL) 
  -1 Part: Phosphotungstic Acid Solution (HT152-250mL) 
  -2Part: Distilled Water 
Aniline Blue Solution 1% 
Acetic Acid Solution 1% 
 -1 mL: Glacial acetic acid 
 -99 mL: Distilled Water 
 
Procedure of Trichrome Staining: (Used for slides set in Paraffin) 
1. Dehydrated slides in Xylene I for 3 minutes 
2. Dehydrated slides in Xylene II for 3 minutes 
3. Dehydrated slides in Xylene III for 3 minutes 
4. Dehydrated slides in 100% ETOH for 3 minutes 
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5. Dehydrated slides in 100% ETOH for 3 minutes 
6. Dehydrated in 95% ETOH for 1 minute 
7. Dehydrated in 70% ETOH for 1 minute 
8. Rinsed slides well with distilled water 
9. Mordant the sections in Bouin solution for 1 hour at 56°C 
10. Removed slides from oven, allowed to cool, washed in running water until the yellow color 
disappeared 
11. Stained sections in Weigert hematoxylin for 10 minutes 
12. Washed in warm running tap water for 10 minutes 
13. Stained sections in Beirich scarlet-acid fuchsin solution for 3 minutes 
14. Rinsed in distilled water 
15. Places slides in Phosphomoybdic/Phosphotungstic acid solution for 15 minutes.  Solution was 
discarded after use. 
16. Stained sections were placed in aniline blue solution for 5 minutes 
17. Slides were rinsed in distilled water 
18. Slides were placed in 1% acetic acid solution for 5 minutes.  Solution was discarded after use. 
19. Rinsed in several changes of tap water 
20. Slides were dehydrated through several graded alcohols, clear in two changes of Xylene and 
Mounted with cytoseal. 
 
 
 
 
 
 
 
 
 
 
 
 45 | P a g e  
 
Modified Movat’s Pentachrome Staining 
The following reagents were used for the Pentachrome stain: 
1% Alcian Blue (good for 6 months): 
 -Alcian Blue (8GX) -1 g 
 -Distilled water- 100 mL 
Alkaline Alcohol (good for 3 months): 
 -95% ethanol -45 mL 
 -Ammonium hydroxide, conc- 5 mL 
Weigert’s Stain Stock Solutions: 
 Alcoholic Hematoxylin 2% (good for 3 months) 
  -Hematoxylin (Sigma H3136) – 10g 
  -95% ethanol- 500 mL 
 Ferric Chloride 
  -Ferric Chloride Hexahydrate- 12.4 g 
  -Distilled Water- 500 mL 
  -HCl, conc- 5 mL 
 Iodine Solution (good for 6 months)** 
  -Iodine- 2 g 
  -Potassium Iodide(KI) – 4 g 
  -Distilled water- 100 mL 
 **Dissolved 4g of potassium Iodide in 20mL of distilled water.  Added 2g of Iodide and 
completely dissolved then added the remaining 80mL of distilled water. 
 Working Solution***: 
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 -Hematoxylin 2% - 30mL 
 -Ferric Chloride- 20mL 
 -Iodine Solution – 10mL 
***Mixed in the order given, discarded after use. 
Crocein Scarlet-Acid Fuchsin 
 1% Crocein Scarlet (good for 6 months) 
  -Crocein Scarlet M00 3B- 1g 
  -Distilled water- 99.5 mL 
  -Acetic Acid, conc- 0.5 mL 
 0.01% Acid Fuchin (good for 6 months) 
  -Acid Fuchsin- 0.1 g 
  -Distilled water- 99.5 mL 
  -Acetic Acid, conc- 0.5 mL 
 Working Solution: 
 4 parts 1% Crocein Scarlet 
 1 part 0.01% Acid Fuchin 
Acetic Acid 1% 
 Acetic acid, conc Glacial- 1mL 
 Distilled water- 99mL 
Phosphotungstic Acid 5% 
 Phosphotungstic Acid- 5g 
 Distilled Water- 100 mL 
Alcoholic Saffrom**** (good for 1 year) 
 Saffron (Sigma S8381)- 6g 
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 Absolute EtOH- 100 mL 
****Placed in an air tight bottle in 60°C oven for 48 hours to extract saffron 
 
Procedure for Pentachrome staining (Used for slides set in Paraffin) 
1. Deparafinized and hydrated to dH2O 
2. Preheated alkaline alcohol in 60°C oven or water bath 
3. Mordant in Bouin’s in 80-90°C water bath for 10 minutes.  (contained formaldehyde and picric 
acid-seal bucket with parafilm to minimize fumes; Sigma HT10-1-32) 
4. Cooled for 10 minutes in room temperature water 
5. Rinsed under running water for 10 minutes 
6. Placed in 1% Alcian Blue for 20 minutes   (At this time the Weigert’s and Crocein Scarlet Acid 
Fuchsin working solutions were prepared) 
7. Rinsed under running water for 10 minutes 
8. Placed in alkaline alcohol at 60°C for 10 minutes 
9. Rinsed under running water for 5 minutes 
10. Placed in Weigert’s for 60 minutes 
11. Washed for 5 minutes in running water, then rinsed in double distilled water for 10 minutes 
12. Placed in Crocein Scarlet Acid Fuchsin for 45 seconds 
13. Rinsed twice (2X) for 5 minutes in water 
14. Placed in 5% Phosphotungsitic Acid  for 5 minutes 9the for 10 and 20 minutes for progressively 
less elastic fibers) 
15. Transferred directly to 1% acetic acid for 5 minutes 
16. Rinsed twice (2x) for 5 minutes in water 
17. Dehydrated in short series 1 change for 1 minute each in 95% EtOH, Twice in 100% EtOH 
18. Placed in alcoholic saffron for 60 minutes 
19. Rinsed in two changes of Absolute EtOH, 1 minute for each 
20. Cleared in xylene and mounted    
 
